Tert-Butyl 2-Oxa-3-Azabicyclo[2.2.1]Hept-5-Ene-3-Carboxylate

Published date: 2024-09-23 14:59:47

Name	Tert-Butyl 2-Oxa-3-Azabicyclo[2.2.1]Hept-5-Ene-3-Carboxylate	CAS#	99027-90-4
Price	￥Inquiry/25kg	Purity	95.0%
Stocking Period	Inquiry	Stock	Inquiry

Detail Product Information Chemical & Physical Properties: CAS Number: 99027-90-4 Name: Tert-Butyl 2-Oxa-3-Azabicyclo[2.2.1]Hept-5-Ene-3-Carboxylate Molecular Formula: C10H15NO3 Molecular Weight: 197.23100 Density: N/A Boiling Point: N/A Melting Point: N/A Flash Point: N/A

Zhongshan Kexin Biotechnology Co., Ltd

Chemsrc Level: Unverified
Tel: 13225699413
Address: 4/F, Jinjia Chuangxingang, West District, Zhongshan City, Guangdong Province, China
Area: China
Contact: Mr zhang
Contact Phone #: 13225699413
Email: 168502503@qq.com
Website: http://
Major Market:
Annual Trade Volume:
Foreign Trade % of Sales:
Major partners:

Zhongshan Kexin Biotechnology Co., Ltd. is a high-tech enterprise located in Zhongshan City, Guangdong Province, China. It is committed to innovative research and production of pharmaceutical intermediates and cosmetic raw materials. The company has gathered a group of research teams with profound professional knowledge and rich practical experience in the field of biomedicine. They rely on cutting-edge biotechnology, constantly explore and break through, aiming to provide efficient, safe, and innovative product solutions for the global pharmaceutical and beauty industry.

Kexin Biotechnology adheres to the corporate philosophy of "technology leads the future, integrity creates quality". Through a strict quality control system and continuous technological innovation, we ensure that every product can meet or even exceed industry standards. Our products are widely used in various fields such as medicine, cosmetics, and health food, providing customized services to partners and helping customers achieve product differentiation and market competitiveness.

Looking ahead to the future, Zhongshan Kexin Biotechnology Co., Ltd. will continuously strengthen research and development investment, expand international cooperation, and embrace the opportunities and challenges of the global market with an open attitude, committed to becoming a leader in the field of biopharmaceutical technology.